Skip to content

NICE lets NHS talking therapies use the Limbic Access chatbot

NICE cites a study in which NHS services using the Limbic Access referral chatbot saw referrals rise 15% against 6% in control services, with larger rises in minority groups.

2
Benefit status
Reported
Evidence
Found by a court or regulator
Source published
Sources
3 publications

Benefits

Benefit

Referrals rise by 15%, against 6% in control services

Awaiting review

Outcome identifiers

Unresolved

Not reviewedUnresolved

Category

Increased Inclusion

Awaiting review

Status

Reported benefit

Awaiting review

Beneficiary groups

Society.

Awaiting review

Beneficiaries

Unresolved

Not reviewedUnresolved

Reach

Unresolved

Not reviewedUnresolved

Distribution and access

Unresolved

Not reviewedUnresolved

Duration

Unresolved

Not reviewedUnresolved

Expected?

Yes

Awaiting review

Costs and harms

Unresolved

Not reviewedUnresolved

AI system

System

Limbic Access (AI self-referral chatbot)

Awaiting review

Model

This is an explicit unresolved assignment: the sources on record do not settle this question.

Not reviewedUnresolved

Release

Unresolved

Not reviewedUnresolved

Provider

Unresolved

Not reviewedUnresolved

Role

Unresolved

Not reviewedUnresolved

Configuration

Unresolved

Not reviewedUnresolved

Inputs and outputs

Unresolved

Not reviewedUnresolved

Autonomy

Unresolved

Not reviewedUnresolved

Workflow

Services placed the chatbot on their websites as a self-referral route open at all hours. Other referral routes stayed open.

Awaiting review

Human oversight

Unresolved

Not reviewedUnresolved

Relation to AI

The study compared services that adopted the chatbot with control services in routine data. Services were not randomized, so differences between services may explain part of the rise.

Awaiting review

AI contribution

Unresolved

Not reviewedUnresolved

Measurement

Studies

Controlled observational. [1]

Fully reviewed: supporting details for Studies

Review date: 29 October 2026.

Sources: [1]

Study design

Controlled observational. [1]

Fully reviewed: supporting details for Study design

Review date: 29 October 2026.

Sources: [1]

Measurement

Referral volumes and demographics in routine service data, services with the chatbot against control services. [1]

Fully reviewed: supporting details for Measurement

Review date: 29 October 2026.

Sources: [1]

Setting and sample

129,400 patients in NHS Talking Therapies services in England. [1]

Fully reviewed: supporting details for Setting and sample

Review date: 29 October 2026.

Sources: [1]

Measures

Change in referral volume, overall and by group. [1]

Fully reviewed: supporting details for Measures

Review date: 29 October 2026.

Sources: [1]

Comparison

Control services without the chatbot. [1]

Fully reviewed: supporting details for Comparison

Review date: 29 October 2026.

Sources: [1]

Results

15% against 6% rise; nonbinary 179%; ethnic minority 29%. [1]

Fully reviewed: supporting details for Results

Review date: 29 October 2026.

Sources: [1]

Additional value from AI

About 9 percentage points more growth in referrals. [1]

Fully reviewed: supporting details for Additional value from AI

Review date: 29 October 2026.

Sources: [1]

Limitations

Observational; company authors; NICE notes mostly company-sourced evidence. [1]

Fully reviewed: supporting details for Limitations

Review date: 29 October 2026.

Sources: [1]

Denominators

Self-referral through the chatbot. [1]

Fully reviewed: supporting details for Denominators

Review date: 29 October 2026.

Sources: [1]

Materials for replication

None public. [1]

Fully reviewed: supporting details for Materials for replication

Review date: 29 October 2026.

Sources: [1]

Money

Kind of value

The kind of monetary value is unclear.

Not reviewedUnresolved

Amount

The monetary value is not established.

Not reviewedUnresolved

Currency and prices

The currency and price basis are unclear.

Not reviewedUnresolved

Period and unit

The period and unit of the monetary estimate are unclear.

Not reviewedUnresolved

Realization

Whether the monetary value was realized is unclear.

Not reviewedUnresolved

Recipients and payers

The recipients and payers are unclear.

Not reviewedUnresolved

Gross or net

Whether the monetary figure includes costs is unclear.

Not reviewedUnresolved

Included costs

The costs included in the estimate are unclear.

Not reviewedUnresolved

Comparison

The financial comparison is not established.

Not reviewedUnresolved

Method

The method used to calculate monetary value is unclear.

Not reviewedUnresolved

Return and payback

The return on investment or payback period is not established.

Not reviewedUnresolved

People and places

Participants

Developer: Limbic. Operator: NHS Talking Therapies for anxiety and depression services in England.

Awaiting review

Jurisdictions

Benefit: England, United Kingdom. Developer: United Kingdom. Operator: United Kingdom.

Awaiting review

Ownership and control

Unresolved

Not reviewedUnresolved

Dependencies

Unresolved

Not reviewedUnresolved

Cross-border connections

Unresolved

Not reviewedUnresolved

Geopolitical implications

The geopolitical implications are unclear.

Not reviewedUnresolved

Follow-up

Conditions for replication

People have access to a phone or computer. Services have capacity to assess the extra referrals.

Awaiting review

Replication attempts

Unresolved

Not reviewedUnresolved

Later findings

Unresolved

Not reviewedUnresolved

Availability

Unresolved

Not reviewedUnresolved

Institutional decision

A relevant institutional decision has not been established.

Not reviewedUnresolved

Grounds

The grounds for an institutional decision are unclear.

Not reviewedUnresolved

Action and result

The result of an institutional decision is not established.

Not reviewedUnresolved

Success criterion

The criterion for a successful institutional decision is unclear.

Not reviewedUnresolved

Evidence

Source numbers

AIBD-0656-source-0001–0003

Awaiting review

Citations

Numbered references below.

Awaiting review

Language

Unresolved

Not reviewedUnresolved

Source relationships

Independent, Developer

Awaiting review

Original evidence

Unresolved

Not reviewedUnresolved

Access and versions

Unresolved

Not reviewedUnresolved

Supported findings

Unresolved

Not reviewedUnresolved

Evidence strength

Found by a regulator. Sources: two independent regulatory documents and the makers' peer-reviewed study. The cited evidence includes no independent study or report. [1] [2] [3]

Fully reviewed: supporting details for Evidence strength

Review date: 29 October 2026.

Sources: [1] [2] [3]

Missing evidence

Unresolved

Not reviewedUnresolved

Grades

Assessed benefits

Society.

Awaiting review

Depth

Society: 2.

Awaiting review

Reasons

Society: Referrals rose 15% in services using the chatbot against 6% in control services, with rises of 179% for nonbinary people and 29% for ethnic minority people.

Awaiting review

Observed or intended

Unresolved

Not reviewedUnresolved

Rubric

Unresolved

Not reviewedUnresolved

Assessor and date

Unresolved

Not reviewedUnresolved

Alternative assessments

Unresolved

Not reviewedUnresolved

Fill

Found by a regulator

Awaiting review

Entry details

Kind

The case describes an evaluation or a study. A health technology assessment that cites a multisite observational study. [2]

Fully reviewed: supporting details for Kind

Review date: 29 October 2026.

Sources: [2]

Field

Mental health care access.

Awaiting review

Purpose

Limbic Access was built to take self-referrals and collect assessment information for NHS Talking Therapies. Wider access to referral is part of that purpose.

Awaiting review

Dates

Source published: 5 February 2024. Updated: 29 October 2026.

Awaiting review

Stage

The system was in routine use. NHS Talking Therapies services used the chatbot as a live referral route. [2]

Fully reviewed: supporting details for Stage

Review date: 29 October 2026.

Sources: [2]

Version

SHA-256: 7cbd4ecad721…

Awaiting review: supporting details for Version

SHA-256 of the public case, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.

References

Other identifiers

Unresolved

Not reviewedUnresolved

Category mappings

Unresolved

Not reviewedUnresolved

Citable summary

Unresolved

Not reviewedUnresolved

Revisions

1 revision. Latest: 29 October 2026.

Awaiting review

Sources

  1. Peer-reviewed study Developer

    Habicht J, Viswanathan S, Carrington B, Hauser TU, Harper R, Rollwage M. Closing the accessibility gap to mental health treatment with a personalized self-referral chatbot. Nature Medicine. 2024;30:595-602.

  2. Regulatory document Independent author

    National Institute for Health and Care Excellence. Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment. HealthTech guidance HTG756, section 3: Committee discussion. 24 July 2025.

  3. Regulatory document Independent author

    National Institute for Health and Care Excellence. HTG756, section 1: Recommendations. 24 July 2025.

Cite this case

BibTeX Download BibTeX

Version 7cbd4ecad721, archived in the edition of 29 October 2026

Benefit marks

Depth

The number and color show the depth of a benefit.

  1. Depth 1. A convenience, or time or money saved.
  2. Depth 2. A measurable improvement in a result or ability.
  3. Depth 3. A lasting change, an ability restored, or a risk removed.
  4. Depth 4. A serious harm averted or a serious condition resolved in time.
  5. Depth 5. A life or livelihood preserved, or a change documented across a population.

Beneficiary

  • Circle: a person
  • Square: an organization
  • Triangle: society

Evidence

  • Solid. A court or regulator found a benefit, or researchers independently studied it.

  • Hatched. Independent reporting.

  • Outline. Claimed by the parties. Only the people or organizations involved, or sources whose independence has not been assessed, support the benefit.

The fill changes with the evidence. The depth color stays the same.

How benefits are assessed